Loading
Stable Angina Pectoris Associated With Depression / Ginkgo biloba dropping pills，best western medicine treatment / Mimetic drug of ginkgo biloba dropping pills，best western medicine treatment · Phase 4 Trial
ClinicalTrials.gov · August 17, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed Phase 4 registration record for a trial of Ginkgo biloba dropping pills added to standard western medicine in stable angina pectoris with depression. No results are posted in this registry record; the study enrolled 74 participants and planned to measure angina frequency and quality of life (SAQ scores) over 12 weeks, but outcome data are not yet available.
Phase 4, Interventional, Randomized, Parallel, Double masking, Treatment purpose. Stable Angina Pectoris Associated With Depression; age from 18 Years; to 75 Years; accepts healthy volunteers. Intervention: The treatment group. Compared with: The control group — Placebo Comparator. n = 74. 4 sites: China.
This is a completed Phase 4 registration record for a trial of Ginkgo biloba dropping pills added to standard western medicine in stable angina pectoris with depression. No results are posted in this registry record; the study enrolled 74 participants and planned to measure angina frequency and quality of life (SAQ scores) over 12 weeks, but outcome data are not yet available.
This is a registry record only; no results are reported, so efficacy and safety cannot be determined from this source.
The source did not state who this applies to in practice.
This is a completed Phase 4 registry record with no reported results; the study design and planned endpoints are documented but outcomes remain unpublished.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT04529148). This is a study registration, not published results. Lead sponsor: Wanbangde Pharmaceutical Group Co., LTD. Recruitment status: COMPLETED. Phase: PHASE4. Study type: INTERVENTIONAL. Enrollment: 74 participants (ACTUAL). Conditions: Stable Angina Pectoris Associated With Depression. Interventions: DRUG: Ginkgo biloba dropping pills，best western medicine treatment; DRUG: Mimetic drug of ginkgo biloba dropping pills，best western medicine treatment. Primary outcome measures: Score of Seattle Angina Questionnaire（SAQ ） , at the 0-week; Score of Seattle Angina Questionnaire（SAQ ） , at the 4-week; Score of Seattle Angina Questionnaire（SAQ ） , at the 8-week; Score of Seattle Angina Questionnaire（SAQ ） , at the 12-week; Frequency of angina pectoris related symptoms every week , at the 0-week; Frequency of angina pectoris related symptoms every week , at the 1-week; Frequency of angina pectoris related symptoms every week , at the 2-week; Frequency of angina pectoris related symptoms every week , at the 3-week; Frequency of angina pectoris related symptoms every week , at the 4-week; Frequency of angina pectoris related symptoms every week , at the 5-week; Frequency of angina pectoris related symptoms every week , at the 6-week; Frequency of angina pectoris related symptoms every week , at the 7-week; Frequency of angina pectoris related symptoms every week , at the 8-week; Frequency of angina pectoris related symptoms every week , at the 9-week; Frequency of angina pectoris related symptoms every week , at the 10-week; Frequency of angina pectoris related symptoms every week , at the 11-week; Frequency of angina pectoris related symptoms every week , at the 12-week. Brief summary: To evaluate the clinical efficacy of Ginkgo biloba dropping pills on improving the frequency of angina pectoris and the life quality of patients with stable angina pectoris and depression symptoms on the basis of the best western medicine treatment; Study on the clinical pharmacological mechanism of Ginkgo biloba dropping pills.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.